Autoantibodies directed against galectin-3 were first described in people with multiorgan IgG4-RD who predominantly presented with type 1 AIP and IgG4-related sialadenitis, two glandular organs that secrete bicarbonate-rich fluids (11). Here, LGALS3 is linked to immunoglobulin G4-related sclerosing disease.